CDC issued a new chikungunya travel notice for Mauritius on May 14, 2026 — now the fourth simultaneous active chikungunya outbreak notice alongside Suriname, French Guiana, and Mayotte. The FDA-approved Ixchiq vaccine is available but widely underutilized. Here is the full warning.